
Roquette Acquires IFF Pharma, Reorganizes into Two Business Groups
Roquette completes IFF Pharma Solutions acquisition and unveils new structure for global growth and innovation.
Roquette completes IFF Pharma Solutions acquisition and unveils new structure for global growth and innovation.
Roquette, a French multinational supplier of pharmaceutical and nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish start-up Biograil.
Roquette, a plant-based ingredients and pharmaceutical excipients manufacturer, announced today an agreement to acquire IFF Pharma Solutions, an excipients for oral dosage solutions producer, to reinforce its position as a major partner to the pharmaceutical industry.
French plant ingredients supplier Roquette, which is also is a leading player in naturally-derived pharmaceutical excipients, has agreed to acquire Qualicaps, a producer of hard capsules and pharmaceutical processing equipment for oral dosage.
Roquette, a French-based multinational provider of pharmaceutical and nutraceutical excipients, has opened a new Pharmaceutical Innovation Center near Philadelphia in Pennsylvania, USA, complementing its other centers in France and Singapore.
Roquette, a French-based provider of pharmaceutical and nutraceutical excipients, has acquired Crest Cellulose, an Indian excipient manufacturer, reinforcing its presence in India and Asia.
French firm Roquette has announced plans to spend €25 million to upgrade its liquid and powder polyols plant in Lestrem between 2022 and 2024. Roquette said the investment will strengthen its position as a leader in polyols and establish a strong reliable supply in the long term.
Plant ingredients supplier Roquette, which is also is a leading player in naturally-derived pharmaceutical excipients, has announced plans for a new innovation center at its US site in Spring House, Pennsylvania. The complex due to open in summer 2022 will house Roquette Pharmaceutical Solutions’ headquarters and serve as a global hub for R&D.